Metformin use in chronic kidney disease: new evidence to guide dosing

Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function

(2013) Janna K. Duong et al.   CLINICAL PHARMACOKINETICS

Metformin therapy in patients with chronic kidney disease

(2012) J. K. Duong et al.   DIABETES OBESITY & METABOLISM

Establishment of a Database of Metformin Plasma Concentrations and Erythrocyte Levels in Normal and Emergency Situations

(2011) Jean-Daniel Lalau et al.   CLINICAL DRUG INVESTIGATION

Clinical Pharmacokinetics of Metformin

(2011) Garry G. Graham et al.   CLINICAL PHARMACOKINETICS

Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency

(2011) K. J. Lipska et al.   DIABETES CARE

Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?

(2011) Helen J. Nye et al.   NEPHRON CLINICAL PRACTICE

Population Exposure-Response Modeling of Metformin in Patients With Type 2 Diabetes Mellitus

(2008) Ying Hong et al.   JOURNAL OF CLINICAL PHARMACOLOGY